One-time cell therapy controls HIV infection in early human study

ctvnews.ca

A small study shows a one-time cell therapy can control HIV infection by re-engineering a patient's own immune cells. This CAR-T therapy, involving altered T-cells, successfully controlled the virus in two of three participants who stopped antiretroviral treatment. Researchers aim to make this therapy accessible, unlike previous donor-based cures, and are investigating why some patients responded better.


With a significance score of 6.2, this news ranks in the top 0.1% of today's 33840 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: